Granulocyte colony stimulating factor promotes scarless tissue regeneration.
CP: Stem cell research
CXCR2
G-CSF
fibrosis
macrophages
mouse injury model
neutrophils
scRNA-seq
tissue regeneration
wound healing
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
21 Sep 2024
21 Sep 2024
Historique:
received:
20
03
2024
revised:
19
07
2024
accepted:
27
08
2024
medline:
22
9
2024
pubmed:
22
9
2024
entrez:
22
9
2024
Statut:
aheadofprint
Résumé
Mammals typically heal with fibrotic scars, and treatments to regenerate human skin and hair without a scar remain elusive. We discovered that mice lacking C-X-C motif chemokine receptor 2 (CXCR2 knockout [KO]) displayed robust and complete tissue regeneration across three different injury models: skin, hair follicle, and cartilage. Remarkably, wild-type mice receiving plasma from CXCR2 KO mice through parabiosis or injections healed wounds scarlessly. A comparison of circulating proteins using multiplex ELISA revealed a 24-fold higher plasma level of granulocyte colony stimulating factor (G-CSF) in CXCR2 KO blood. Local injections of G-CSF into wild-type (WT) mouse wound beds reduced scar formation and increased scarless tissue regeneration. G-CSF directly polarized macrophages into an anti-inflammatory phenotype, and both CXCR2 KO and G-CSF-treated mice recruited more anti-inflammatory macrophages into injured areas. Modulating macrophage activation states at early time points after injury promotes scarless tissue regeneration and may offer a therapeutic approach to improve healing of human skin wounds.
Identifiants
pubmed: 39306847
pii: S2211-1247(24)01093-3
doi: 10.1016/j.celrep.2024.114742
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114742Informations de copyright
Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of interests A provisional patent has been filed with the US Patent and Trademark Office regarding CXCR2, G-CSF, and NETosis on reducing scar formation and promoting tissue regeneration.